<DOC>
	<DOCNO>NCT01817777</DOCNO>
	<brief_summary>MTF116086 open-label , randomise , parallel-design study subject type II diabetes . The study site-based , local pharmacy serve site pharmacist principal investigator site . All subject enter initial 8-week observational phase purchase behaviour compliance usual metformin use observe record . At end observational phase , subject randomise one two arm ( metformin small pack vs. metformin large pack ) 20-week interventional phase . The medication interventional phase provide subject free charge . HbA1c collect subject Week 0 , Week 8 , Week 28 . Subjects ask question tablet compliance , satisfaction pack size receive reason miss dos throughout interventional phase pharmacist . The pharmacy visit Week 28 end study .</brief_summary>
	<brief_title>An Open Study Evaluate Whether Pack Size Affects Compliance Metformin Treatment Subjects With Type II Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Males female age &gt; =18 year Diagnosis type II diabetes HbA1c value high 9.0 % Evidence physiciansupplied prescription metformin use Stable dose metformin 3 month prior enrolment Written inform consent subject Current use antidiabetic medication metformin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Socioeconomic category</keyword>
	<keyword>Medication compliance</keyword>
	<keyword>Metformin</keyword>
	<keyword>small pack</keyword>
</DOC>